Metabolome profiling by HRMAS NMR spectroscopy in pancreatic adenocarcinoma

Key Points

• Metabolome profiling reveals distinct biomarkers associated with pancreatic adenocarcinoma.
• In-depth NMR spectroscopy analysis highlights specific metabolic alterations in cancerous tissue.
• The study assesses metabolic changes in tumor samples, aiming to improve diagnostic approaches.
• Findings may enable the development of targeted interventions in pancreatic cancer management.

Abstract